These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 9704864)

  • 1. Lactic acid bacteria as antigen delivery vehicles for oral immunization purposes.
    Pouwels PH; Leer RJ; Shaw M; Heijne den Bak-Glashouwer MJ; Tielen FD; Smit E; Martinez B; Jore J; Conway PL
    Int J Food Microbiol; 1998 May; 41(2):155-67. PubMed ID: 9704864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lactic acid bacteria--20 years exploring their potential as live vectors for mucosal vaccination.
    Wyszyńska A; Kobierecka P; Bardowski J; Jagusztyn-Krynicka EK
    Appl Microbiol Biotechnol; 2015 Apr; 99(7):2967-77. PubMed ID: 25750046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineering lactococci and lactobacilli for human health.
    Bermúdez-Humarán LG; Aubry C; Motta JP; Deraison C; Steidler L; Vergnolle N; Chatel JM; Langella P
    Curr Opin Microbiol; 2013 Jun; 16(3):278-83. PubMed ID: 23850097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Animal vaccines based on orally presented yeast recombinants.
    Shin MK; Yoo HS
    Vaccine; 2013 Sep; 31(40):4287-92. PubMed ID: 23891501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selection of new lactic acid bacteria strains bearing probiotic features from mucosal microbiota of healthy calves: Looking for immunobiotics through in vitro and in vivo approaches for immunoprophylaxis applications.
    Sandes S; Alvim L; Silva B; Acurcio L; Santos C; Campos M; Santos C; Nicoli J; Neumann E; Nunes Á
    Microbiol Res; 2017 Jul; 200():1-13. PubMed ID: 28527759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lactic acid bacteria - promising vaccine vectors: possibilities, limitations, doubts.
    Szatraj K; Szczepankowska AK; Chmielewska-Jeznach M
    J Appl Microbiol; 2017 Aug; 123(2):325-339. PubMed ID: 28295939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and delivery of heterologous antigens using lactic acid bacteria.
    Reuter MA; Hanniffy S; Wells JM
    Methods Mol Med; 2003; 87():101-14. PubMed ID: 12958452
    [No Abstract]   [Full Text] [Related]  

  • 8. Lactic acid bacteria as live vaccines.
    Mercenier A; Müller-Alouf H; Grangette C
    Curr Issues Mol Biol; 2000 Jan; 2(1):17-25. PubMed ID: 11464916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting mucosal dendritic cells with microbial antigens from probiotic lactic acid bacteria.
    Mohamadzadeh M; Duong T; Hoover T; Klaenhammer TR
    Expert Rev Vaccines; 2008 Mar; 7(2):163-74. PubMed ID: 18324887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucosal vaccination and therapy with genetically modified lactic acid bacteria.
    Wells J
    Annu Rev Food Sci Technol; 2011; 2():423-45. PubMed ID: 22129390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Adhesion of lactic acid bacteria to epithelium of different cavities of the human organism].
    Kovalenko NK; Podgorskiĭ VS; Kasumova SA
    Mikrobiol Z; 2004; 66(4):62-8. PubMed ID: 15515903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lactic acid bacteria as mucosal delivery vehicles: a realistic therapeutic option.
    Wang M; Gao Z; Zhang Y; Pan L
    Appl Microbiol Biotechnol; 2016 Jul; 100(13):5691-701. PubMed ID: 27154346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytoplasmic expression of a model antigen with M Cell-Targeting moiety in lactic acid bacteria and implication of the mechanism as a mucosal vaccine via oral route.
    Oh SH; Kim SH; Jeon JH; Kim EB; Lee NK; Beck S; Choi YJ; Kang SK
    Vaccine; 2021 Jul; 39(30):4072-4081. PubMed ID: 34127296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucosal vaccine delivery of antigens tightly bound to an adjuvant particle made from food-grade bacteria.
    van Roosmalen ML; Kanninga R; El Khattabi M; Neef J; Audouy S; Bosma T; Kuipers A; Post E; Steen A; Kok J; Buist G; Kuipers OP; Robillard G; Leenhouts K
    Methods; 2006 Feb; 38(2):144-9. PubMed ID: 16414272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucosal Lactobacillus vectored vaccines.
    Yu Q; Zhu L; Kang H; Yang Q
    Hum Vaccin Immunother; 2013 Apr; 9(4):805-7. PubMed ID: 23322214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lactic acid bacteria as oral delivery systems for biomolecules.
    Berlec A; Ravnikar M; Strukelj B
    Pharmazie; 2012 Nov; 67(11):891-8. PubMed ID: 23210237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lactic acid bacteria protect human intestinal epithelial cells from Staphylococcus aureus and Pseudomonas aeruginosa infections.
    Affhan S; Dachang W; Xin Y; Shang D
    Genet Mol Res; 2015 Dec; 14(4):17044-58. PubMed ID: 26681052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic transformation of novel isolates of chicken Lactobacillus bearing probiotic features for expression of heterologous proteins: a tool to develop live oral vaccines.
    Mota RM; Moreira JL; Souza MR; Horta MF; Teixeira SM; Neumann E; Nicoli JR; Nunes AC
    BMC Biotechnol; 2006 Jan; 6():2. PubMed ID: 16396687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New strategies for using mucosal vaccination to achieve more effective immunization.
    Walker RI
    Vaccine; 1994 Apr; 12(5):387-400. PubMed ID: 8023545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant lactic acid bacteria as delivery vectors of heterologous antigens: the future of vaccination?
    Trombert A
    Benef Microbes; 2015; 6(3):313-24. PubMed ID: 25245573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.